Clinical Trial Update: Role of the Melanocortin-4 Receptor in Hypoactive Sexual Desire Disorder [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial examining the role of the melanocortin-4 receptor in hypoactive sexual desire disorder has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoactive Sexual Desire Disorder

Snippet

Sponsor: Imperial College Healthcare NHS Trust | Conditions: Hypoactive Sexual Desire Disorder | Phase 4 | Status: COMPLETED | Results posted: 2024-08-09